FDA HIV drug, Iron Deficiency
FDA HIV drug
|Updated: 5/10/2012 5:49 pm
||Published: 5/10/2012 4:24 pm
A drug which could prevent healthy people from becoming affected with HIV is one step closer to approval.
An FDA panel met today in Maryland to discuss whether Truvada is safe and effective.
If it's approved, Truvdea would be a major breakthrough in the 30-year campaign against the aids epidemic.
Some doctors already prescribe it as a preventive measure.
But FDA approval would allow the drug maker Gilead Sciences to formally market its drug for that use.
Newborns whose mothers are under stress during the first trimester may be at risk for iron deficiency.
They recruited pregnant woman from a war zone in Israel.
Some became pregnant while rocket attacks were occurring, and some after the attacks stopped.
Results show the women who were in their first trimester when rocket attacks occurred had lower cord blood iron concentrations.
The study was presented at the "pediatric academy societies" annual meeting in Boston.
Copyright 2012 Newport Television LLC All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.